Cargando…
Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery
We aimed to examine the usefulness of serum glutathione peroxidase 3 (GPx3) as a biomarker of lung cancer recurrence after complete resection. We prospectively collected serial serum samples at the baseline, as well as 3, 6 and 12 months after surgery from complete resection cases in 2013. GPx3 leve...
Autores principales: | Kho, Bo Gun, Park, Ha-Young, Cho, Hyun-Joo, Park, Cheol Kyu, Kim, Young-Chul, Yun, Ju-Sik, Song, Sang-Yun, Na, Kook-Joo, Choi, Yoo-Duk, Lee, Seung-Won, Oh, In-Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760369/ https://www.ncbi.nlm.nih.gov/pubmed/33255360 http://dx.doi.org/10.3390/jcm9123801 |
Ejemplares similares
-
Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells
por: An, Byung Chull, et al.
Publicado: (2016) -
Pulmonary epithelioid hemangioendothelioma misdiagnosed as a benign nodule
por: Kim, Minah, et al.
Publicado: (2015) -
Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
por: Park, Seongho, et al.
Publicado: (2019) -
Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board
por: Kim, Min-Seok, et al.
Publicado: (2020) -
Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2019)